The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

LECTADE Plus Powder for Oral Solution

Elanco GmbHVPA22020/030/001

Main Information

Trade NameLECTADE Plus Powder for Oral Solution
Active SubstancesSodium chloride
Potassium dihydrogen phosphate
Sodium acid citrate
Potassium citrate
Sodium citrate
Glucose monohydrate
Dosage FormPowder for oral solution
Licence HolderElanco GmbH
License Holder AddressHeinz-Lohmann-Strasse 4
27472 Cuxhaven
Licence NumberVPA22020/030/001

Group Information

ATC CodeQA07CQ02 oral electrolytes and carbohydrates
Therapeutic ClassElectrolytes


License statusAuthorised
Licence Issued21/03/2011
Legal StatusLR: Licensed Retailer as defined in national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back